EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Rapamycin Conditioning of Dendritic Cells Differentiated from Human ES Cells Promotes a Tolerogenic Phenotype

Kathryn M Silk, Alison J Leishman, Kevin P Nishimoto, Anita Reddy, Paul J Fairchild

Journal of Biomedicine and Biotechnology · 2012 · 2012 · 1-11

DOI: 10.1155/2012/172420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedicine and Biotechnology, 2012. Verfasst von Kathryn M Silk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the establishment of immunological tolerance, we have proposed that DC, rendered tolerogenic during their differentiation from hESC, might predispose recipients to accept replacement tissues. As a first step towards this goal, we demonstrate that DC differentiated from H1 hESCs (H1-DCs) are particularly responsive to the immunosuppressive agent rapamycin compared to monocyte-derived DC (moDC). While rapamycin had only modest impact on the phenotype and function of moDC, H1-DC failed to upregulate CD40 upon maturation and displayed reduced immunostimulatory capacity. Furthermore, coculture of naïve allogeneic T cells with rapamycin-treated H1-DC promoted an increased appearance of CD25 hi Foxp3 + regulatory T cells, compared to moDC. Our findings suggest that conditioning of hESC-derived DC with rapamycin favours a tolerogenic phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesCell DifferentiationCell LineCells, CulturedDendritic CellsEmbryonic Stem CellsHumansImmune ToleranceImmunosuppressive AgentsPhenotypeSirolimus

Substanzen

Immunosuppressive AgentsSirolimus

Autor:innen und Institutionen

  • Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.

Förderung

  • Medical Research Council

Zitieren

APA

Silk, K. M., Leishman, A. J., Nishimoto, K. P., Reddy, A., & Fairchild, P. J. (2012). Rapamycin Conditioning of Dendritic Cells Differentiated from Human ES Cells Promotes a Tolerogenic Phenotype. Journal of Biomedicine and Biotechnology, 2012, 1-11. https://doi.org/10.1155/2012/172420

Vancouver

Silk KM, Leishman AJ, Nishimoto KP, Reddy A, Fairchild PJ. Rapamycin Conditioning of Dendritic Cells Differentiated from Human ES Cells Promotes a Tolerogenic Phenotype. Journal of Biomedicine and Biotechnology. 2012;2012:1-11. doi:10.1155/2012/172420

BibTeX
@article{Silk2012,
  author = {Silk, Kathryn M and Leishman, Alison J and Nishimoto, Kevin P and Reddy, Anita and Fairchild, Paul J},
  title = {Rapamycin Conditioning of Dendritic Cells Differentiated from Human ES Cells Promotes a Tolerogenic Phenotype},
  journal = {Journal of Biomedicine and Biotechnology},
  year = {2012},
  volume = {2012},
  pages = {1--11},
  doi = {10.1155/2012/172420}
}
Kostenlos starten →